Exhibit A

JOINT FILING AGREEMENT

The undersigned agree that this Schedule 13G Amendment No. 1 dated February 12, 2025 relating to the Common Stock, par value $0.001 per share, of Marinus Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.

 

SOFINNOVA INVESTMENTS, INC.

 

By: /s/ James Healy

  Name: James Healy
  Title:   Director

 

 

 

SOFINNOVA BIOEQUITIES GP LLC

 

By: /s/ Eric Delbridge

  Name: Eric Delbridge
  Title:   Managing Member

 

 

 

JAMES HEALY

 

By: /s/ James Healy

 

 

 

ERIC DELBRIDGE

 

By: /s/ Eric Delbridge

 

 

 

 

 

 

 

Exhibit B

CONTROL PERSON IDENTIFICATION

Sofinnova Investments, Inc. and Sofinnova BioEquities GP LLC are the relevant entities for which James Healy and Eric Delbridge, respectively, may be considered control persons.

 

 

Marinus Pharmaceuticals (NASDAQ:MRNS)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Marinus Pharmaceuticals 차트를 더 보려면 여기를 클릭.
Marinus Pharmaceuticals (NASDAQ:MRNS)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Marinus Pharmaceuticals 차트를 더 보려면 여기를 클릭.